article thumbnail

Bayer triples sales forecast for prostate cancer drug Nubeqa

pharmaphorum

Bayer now says it expects to make €3 billion in sales for its prostate cancer treatment Nubeqa, up from an earlier estimate of €1 billion, after reviewing new data for the drug in metastatic hormone-sensitive tumours. The post Bayer triples sales forecast for prostate cancer drug Nubeqa appeared first on.

Sales 96
article thumbnail

Foods, supplements, and medicine: the new frontier in chronic disease treatment

pharmaphorum

The mass-scale production, packaging, and distribution of these ultra-processed foods and their subsequent sale in schools and supermarkets can lead to intellectual and developmental delays, anti-social behavior, and ADHD in children. The most powerful tool we have in our arsenal to reverse the global chronic disease epidemic is food.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Bayer sells testosterone drug rights to Grünenthal for €500m

pharmaphorum

Grünenthal is paying up to €500 million ($501 million) for rights to Nebido (testosterone undecanoate), which is sold in around 80 countries worldwide for testosterone deficiency and made sales of €117 million last year.

Drugs 81
article thumbnail

Best Cough Syrups in India

Creogenic Pharma

Our company is ISO-certified and formulates high-quality, low-cost pharma drug solutions that adhere to the latest guidelines, GMP policies, and applicable norms. To deliver top-notch pharma products to every corner of India, we focus on strengthening our franchise channel.

article thumbnail

Russia’s focus on domestic pharma production could shield it from sanctions’ effects

Pharmaceutical Technology

Compared with other emerging pharmaceutical markets (such as India and China, covered in previous Emerging Market Outsourcing Reports), Russian facilities lack many US Food and Drug Administration (FDA) and European Medicines Agency (EMA) approvals, meaning Russian manufacturing is more focused on the domestic market.

article thumbnail

COVID-19 and the digital pharma marketing revolution

pharmaphorum

Until 2020, pharma had lagged other industries in its investment in digital marketing. In the US, TV advertising for pharma products is still a big business, but this is mainly aimed at patients. A report from eMarketer came to an identical conclusion, estimating that US pharma would spend $9.53 This is an increase in 14.2%

article thumbnail

What are the Vital Advantages Offered by PCD Pharma Companies?

Fossil Remedies

With the help of this feature, the franchise partner can pick the targeted areas for the distribution of pharmaceutical products and medicines. The franchise partner gets the freedom of choice to decide the stock and the pcd pharma product list , that would be marketed in a targeted area. It is a profitable business.